TRVI Trevi Therapeutics, Inc.
$13.35▲ +6.71%
Healthcare
Other
After hours
$14.00▲ +4.87%
Oct 27, 5:34 PM ET
Volume 2.09M
Avg Volume (10D) 1.87M
Key Metrics & Fundamentals
Market Cap
$1.90B
P/E Ratio
–
Div Yield
0.00%
52W Range
9.82 - 20.22
% vs 50 MA
-10.95%
% vs 200 MA
-6.70%
RSI-14
48.4
MACD Histogram
+0.1900
Beta (1Y vs SPY)
1.20
Free Cash Flow
-$17.55M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$20.48M
COGS
–
Operating Exp
$20.51M
Operating Income
-$20.51M
EBIT
-$20.51M
Pretax Income
-$17.82M
Net Income
-$17.80M
EPS (Diluted)
-0.11
Price & Volume History
Loading chart…
Recent News
Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference
GlobeNewswire · Oct 27, 2026 7:30 AM ET
Do Trevi Therapeutics’ (TRVI) CORAL Data and GSK’s Exit Reframe Its Chronic Cough Ambitions?
Simply Wall St. · Oct 13, 2026 6:14 PM ET
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
GlobeNewswire · Oct 13, 2026 7:30 AM ET
Top 4 Healthcare Stocks Backed by Raymond James Analysts
Investing.com · Oct 8, 2026 10:09 AM ET
Trevi Therapeutics' Sample Size Re-estimation for Chronic Cough Trial Likely Positive, Oppenheimer Says
MT Newswires · Sep 25, 2026 1:51 PM ET
Trevi Therapeutics Insider Sold Shares Worth $595,806, According to a Recent SEC Filing
MT Newswires · Sep 17, 2026 5:06 PM ET
Trevi Therapeutics (TRVI) Stock Trades At A Premium To Fair Value
Simply Wall St. · Sep 5, 2026 1:05 PM ET
Trevi Therapeutics to Participate in Upcoming September Conferences
GlobeNewswire · Sep 3, 2026 7:30 AM ET
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
GlobeNewswire · Aug 26, 2026 7:30 AM ET
Trevi Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 2:04 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See TRVI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.